Ledyard National Bank’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Ledyard National Bank’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-150	Closed	-$9K	–	730
2018 Q1	$9K	Hold	150	–	–	﹤0.01%	648
2017 Q4	$10K	Hold	150	–	–	﹤0.01%	657
2017 Q3	$10K	Hold	150	–	–	﹤0.01%	656
2017 Q2	$9K	Hold	150	–	–	﹤0.01%	621
2017 Q1	$9K	Hold	150	–	–	﹤0.01%	630
2016 Q4	$8K	Hold	150	–	–	﹤0.01%	519
2016 Q3	$9K	Hold	150	–	–	﹤0.01%	508
2016 Q2	$10K	Hold	150	–	–	﹤0.01%	470
2016 Q1	$9K	Hold	150	–	–	﹤0.01%	541
2015 Q4	$10K	Hold	150	–	–	﹤0.01%	519
2015 Q3	$10K	Hold	150	–	–	﹤0.01%	507
2015 Q2	$12K	Hold	150	–	–	﹤0.01%	495
2015 Q1	$11K	Buy	+150	New	+$11K	﹤0.01%	488

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Ledyard National Bank's PJP Position: Q2 2018 in Review

Ledyard National Bank sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2018, closing a stake of 150 shares — an estimated $9K sold.

Ledyard National Bank first reported a position in PJP in Q1 2015 and held it in 13 quarters. The position peaked at $12K in Q2 2015. 85 funds tracked by Wall St. Rank hold PJP as of Q2 2018.

Ledyard National Bank reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
Ledyard National Bank sold 150 Invesco Pharmaceuticals ETF shares in Q2 2018, an estimated $9K.
Ledyard National Bank first reported a position in Invesco Pharmaceuticals ETF in Q1 2015 and held it in 13 quarters.
Ledyard National Bank's Invesco Pharmaceuticals ETF position peaked at $12K in Q2 2015.
85 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2018.

Based on Ledyard National Bank's 13F filing for Q2 2018, filed 11 Jul 2018.